C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
12/2006
12/19/2006	CA2297439C Carbostyril derivatives
12/14/2006	WO2006133326A1 Inhibitors of hcv replication
12/14/2006	WO2006132432A1 Therapeutic agent for neurogenic pain
12/14/2006	US20060281920 such as 6-(4-ethoxy-phenyl)-2S-hydroxy-3R-[4-(3-methoxy-phenyl)-piperazine-1-carbonyl]-hexanoic acid hydroxyamide, used for the treatment or prophylaxis of arthritis in mammals
12/14/2006	US20060281743 Isoquinolinone potassium channel inhibitors
12/13/2006	EP1731507A1 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents
12/13/2006	EP1731505A1 Alkoxyphenylpropanoic acid derivatives
12/13/2006	EP1730141A1 Compounds for the treatment of diseases
12/13/2006	EP1730103A1 Formamide derivatives useful as adrenoceptor
12/13/2006	EP1729774A1 Pyrrolidine compounds
12/13/2006	EP1385823B1 Guanidino compounds as melanocortin-4 receptor (mc4-r) agonists
12/13/2006	CN1289469C Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
12/12/2006	US7148239 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof
12/12/2006	US7148221 Vanilloid receptor ligands and their use in treatments
12/12/2006	US7148198 Antibacterial agents
12/12/2006	US7147935 Luminescence device and display apparatus
12/07/2006	WO2006129978A1 3,4-dihydroisoquinolinium salt derivatives
12/07/2006	WO2006044362A3 N-sulfonylpiperidine cannabinoid receptor 1 antagonists
12/07/2006	US20060276518 Aryl and heteroaryl compounds and methods to modulate coagulation
12/07/2006	US20060276450 Isoquinoline potassium channel inhibitors
12/07/2006	US20060276409 N-Hydroxy-N-(1-(2-carbamoylalkylaminocarbonyl)ethyl)formamides: [(Formyl-hydroxy-amino)-methyl]-3-cyclopentyl-propionic acid (1-dimethyl-carbamoyl-2,2-dimethyl-propyl)-amide; bacterial polypeptide deformylase inhibitors
12/07/2006	CA2606112A1 3,4-dihydroisoquinolinium salt derivatives
12/06/2006	EP1727789A2 Phenylethanolamine derivatives as beta-2 agonists
12/06/2006	CN1875003A Process for producing dihydroisoquinoline zwitterions and organic catalyst
12/06/2006	CN1874991A Compound capable of binding S1P receptor and pharmaceutical use thereof
12/05/2006	US7144997 Vertebrate embryonic patterning-inducing proteins, compositions and uses related therto
12/05/2006	US7144895 Benzene acetamide compounds useful as serine protease inhibitors
12/05/2006	US7144894 such as 2R-(N-1-t-butyloxycarbonylindol-5-ylmethyl-N-4-chlorophenylsulfonylamino)-4-methyl-pentanamide, used for treatment of Alzheimer's disease or Down's Syndrome
12/05/2006	US7144893 4-aryl quinols and analogs thereof as therapeutic agents
12/05/2006	US7144888 Vanilloid receptor ligands and their use in treatments
12/05/2006	US7144883 Substituted fused ring sulfonamides containing, e.g., naphthalene, isoquinoline, quinoline, benzofuran or benzothiophene rings; treatment of conditions relating to obesity, type II diabetes and CNS disorders
12/05/2006	CA2245728C Isoquinoline derivatives and drugs
11/2006
11/30/2006	WO2006126938A1 Novel 8-sulfonyl-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor
11/30/2006	US20060270704 potassium channel modulators such as 4-(3-fluorophenyl)-6-methoxy-N,N,2-trimethyl-1-oxo-1,2-dihydroisoquinoline-3-carboxamide, used as antiarrhythmia agents; cardiovascular disorders
11/30/2006	US20060270693 Ether derivative
11/30/2006	CA2609735A1 Novel 8-sulfonyl-3 aminosubstituted chroman or tetrahydronaphthalene derivatives modulating the 5ht6 receptor
11/29/2006	EP1032559B1 Aminoalkylphenol derivatives for treating depression and memory dysfunction
11/29/2006	CN1287369C Optical data carrier whose information layer contains light-absorbing compound having a number of chromophoric centers
11/29/2006	CN1286816C Preparation of liensinine, isoliensinine and methylliensinine extracted from lotus seed
11/28/2006	US7141560 For use as analgesic or sedative; treating sleep disorders
11/23/2006	WO2006123020A1 Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4
11/23/2006	US20060264618 Protease inhibitor conjugates and antibodies useful in immunoassay
11/23/2006	US20060264483 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
11/23/2006	CA2609161A1 Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4
11/22/2006	EP1724262A1 1-(2h)-isoquinolone derivative
11/22/2006	EP1723950A2 Method of treating dopaminergic gaba-nergic disorders
11/22/2006	EP1554243B1 Bicyclic benzamide compounds as histamine h3 receptor ligand useful in the treatment of neurological diseases
11/22/2006	EP1511770B1 Glycoprotein vi-fc fusion protein for the treatment of vascular diseases
11/22/2006	EP1120114B1 Compositions and methods for treating conditions responsive to estrogen
11/22/2006	CN1867559A Glutamine fructose-6-phosphate amidotransferase (GFAT) inhibitors
11/22/2006	CN1867542A Process of preparing O-carbamoyl compounds in the presence of active amine group
11/22/2006	CN1285578C Substituted benzoic acid amides and use for inhibition of angiogenesis thereof
11/21/2006	US7138533 acetylcholinesterase inhibitory action and an alpha 1 antagonistic action
11/21/2006	US7138492 Promoting survival of substantia nigra neuronal cells by contacting with a trophic amount of a ptc therapeutic; mimics hedgehog-mediated patched signal transduction; treating or preventing Parkinson's Disease
11/15/2006	EP1720847A1 Histamine-3 receptor modulators
11/15/2006	EP1720829A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
11/15/2006	EP1323711B1 Novel phenylalanine derivatives
11/15/2006	CN1863797A Cyclic amine BACE-1 inhibitors having a benzamide substituent
11/15/2006	CN1863789A Substituted isoquinolinones
11/15/2006	CN1863777A Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
11/14/2006	US7135570 Selective hydrogenation of amino-substituted fused bicyclic aromatic ring system, preparation of racemic amino substituted fused bicyclic ring system via nitrosation, enzymatic resolution of racemic mixture to produce (R)- and (S)-forms
11/14/2006	CA2156432C New derivatives of glutamic and aspartic acids, a method of preparing them, and their use as drugs for enhancing memory and learning
11/14/2006	CA2111386C Substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
11/09/2006	WO2006117549A1 Enzyme inhibitors
11/09/2006	US20060252778 Compounds for the treatment of inflammatory disorders
11/09/2006	CA2599411A1 Enzyme inhibitors
11/08/2006	EP1718616A2 Isoquinoline derivatives
11/08/2006	EP1718342A1 Technetium-and rhenium-bis(heteroaryl) complexes, and methods of use thereof
11/08/2006	EP1080074B1 Heterocyclic substituted amides, their production and their use
11/08/2006	CN1283975C Optical data storage device containing Co-Phthalocyanin complex in optically writable information layer
11/07/2006	US7132568 beta-amino amides; treating degenerative dementias characterized by beta-amyloid deposits in the brain, especially Alzheimer's Disease
11/07/2006	US7132547 Preventives/remedies for urinary disturbance
11/07/2006	US7132445 Antiinflammatory agents; anticancer agents; analgesics; antiarthritic agents; inflammatory bowel disorders; respiratory system disorders
11/02/2006	WO2006099060A3 Process for the preparation of opioid modulators
11/02/2006	WO2006093823A9 2- [ isoquinolin-s - carbonyl ) amino] -propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis
11/02/2006	EP1717230A1 Fused-ring 4-oxopyrimidine derivative
11/02/2006	EP1717220A2 Vanilloid receptor ligands and their use in treatments
11/01/2006	CN1856478A Bicyclic imino acid derivatives as inhibitors of matrix metalloproteinases
11/01/2006	CN1856477A 异喹啉钾通道抑制剂 Isoquinoline potassium channel inhibitors
11/01/2006	CN1856476A Isoquinolinone potassium channel inhibitors
11/01/2006	CN1856475A 异喹啉钾通道抑制剂 Isoquinoline potassium channel inhibitors
11/01/2006	CN1856474A Isoquinolinone potassium channel inhibitors
11/01/2006	CN1856473A Isoquinolinone potassium channel inhibitors
11/01/2006	CN1856472A Isoquinolinone potassium channel inhibitors
11/01/2006	CN1856308A Excitatory amino acid receptor antagonists
10/2006
10/31/2006	US7129360 Using alkylmetal reagents for directed metalation of azaaromatics
10/26/2006	WO2006057950A3 4-phenyl substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
10/26/2006	US20060241153 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide; potent and highly selective inhibitors; coagulation disorders; antithrombotic agents; diagnostic reagents; good bioavailability and/or solubility
10/26/2006	US20060241115 2,3-Dihydro-4H-1,4-benzoxazine derivatives containing an optionally fused pyridine or pyrimidine ring; 7-((6,7-bis(methyloxy)-4-quinolinyl)oxy)-N-phenyl-2,3-dihydro-4H-1,4-benzoxazine-4-carboxamide; kinase inhibitors; inflammation, angiogenesis and cancer
10/26/2006	US20060241110 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents
10/25/2006	EP1713895A1 Alkoxylated polyol containing bleach activating terminating functional groups
10/25/2006	EP1713484A2 Compounds and methods of use
10/25/2006	EP1567501B1 Propanamine derivatives as serotonin and norepinephrine reuptake inhibitors
10/25/2006	EP1519972B1 Compositions for producing aminoplast products and method for producing products from these compositions
10/24/2006	US7125891 Such as (1-((2,3-dihydro-2-(4-propyl-1H-imidazol-2-yl)-1H-indol-1 -yl)carbonyl)propyl)-carbamate; for inactivation of cholecystokinins
10/24/2006	US7125871 Excitatory amino acid receptor modulators
10/24/2006	CA2261848C Cell adhesion inhibitors
10/19/2006	WO2006110516A1 Acylhydrazide p2x7 antagonists and uses thereof
10/19/2006	US20060235049 1-{3-[4-(1-Methyl-pyrrolidin-2-yl)-phenoxy]-propyl}-piperidine, and 1-Benzyl-4-[4-(3-piperidin-1-yl-propoxy)-phenyl]-piperidin-4-ol; histamin receptor antagonist; antidepressant; upper airway allergies, nasal congestion, allergic rhinitis, cognitive dysfunction, schizophrenia, manic disorders
10/19/2006	US20060235019 Substituted quinazolinone compounds

1 ... 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 ... 119